Table 1.

Association between TACC2 immunohistochemical status and clinicopathological parameters in 154 breast carcinoma cases

	TACC2 status
	+(n = 78)	−(n = 76)	P‐value
Agea (years)	56.1 ± 1.5	57.4 ± 1.3	0.53
Menopausal status
Premenopausal	30	25
Postmenopausal	48	51	0.47
Stage
I	36	37
II	29	27
III	13	12	0.95
NAC
Received	11	6
Not received	67	69	0.23
Pathological T factor (pT)
pT1	46	46
pT2‐4	32	40	0.84
Lymph node metastasis
Positive	32	28
Negative	46	48	0.59
Histological grade
1 (well)	25	24
2 (moderate)	31	36
3 (poor)	22	16	0.52
Estrogen receptor (ER) status
Positive	63	62
Negative	15	14	0.90
PR status
Positive	54	55
Negative	24	21	0.67
AR LIa (%)	29.7 ± 3.0	32.8 ± 3.0	0.46
HER2 status
Positive	13	10
Negative	65	66	0.54
Ki‐67 LIa (%)	17.5 ± 1.6	13.4 ± 1.3	0.047

^aData are presented as mean ±SEM.

All other values represent the number of cases. Statistical analysis was evaluated by the Student's t‐test or a cross‐table using the chi‐squared test. P‐values less than 0.05 were considered significant, and described as boldface.